Thursday, 19 December 2013
INFOSYS SAFE BET FOR 2014
SAFE STOCK OF 2013 INFOSYS
STOCK HIT FRESH ALL TIME HIGH 3670 STILL LOOK TO SET VERY STRONG GAINS IN 2014
MY UPDATE ON DEC 19
STOCK WAS TRADING AT 3300 LEVELS WHEN THE MAIL WAS SEND ON NOV 27 2013
TODAY THE STOCK HIT FRESH ALL TIME HIGH 3544.. STILL STOCK IS ONE OF THE SAFEST BEST AND LONG LONG WAY TO GO FORWARD ITS A PURE INVESTMENT CALL WHICH GIVE IMMENSE RETURNS IN COMING MONTHS TO COME
THIS WAS THE MAIL SEND ON NOV 19 TH 2013
INFOSYS SAFE BET FOR 2014
Last few years have not been great for Infosys investors. But it appears this is about to change in 2014. Infosys stock seems set for considerable gains. Here’s why
Infosys stock has broken out on weekly chart above 3000 and the breakout structure seems robust for huge follow through gains. The only issue: patience.
Here’s the Breakout on weekly chart
As you
can see in the weekly chart above, Infosys was struggling below 2995 for
years. But that seems to have changed post its breakout above 2995. The
breakout happened in August and, even when, many months have passed,
stock has not done much. The consolidation appears healthy and does set
the stock for huge gains over next 12 months.
What should one do?
Keep Buying the stock between 3000 and 3300 on regular basis and build position for huge gains in next 12 months. As always, there is no certainty in market and if things turn for worse and Infosys stock slips below 50 week ma, then exit and wait for technical to improve.
STOCK HIT FRESH ALL TIME HIGH 3670 STILL LOOK TO SET VERY STRONG GAINS IN 2014
MY UPDATE ON DEC 19
STOCK WAS TRADING AT 3300 LEVELS WHEN THE MAIL WAS SEND ON NOV 27 2013
TODAY THE STOCK HIT FRESH ALL TIME HIGH 3544.. STILL STOCK IS ONE OF THE SAFEST BEST AND LONG LONG WAY TO GO FORWARD ITS A PURE INVESTMENT CALL WHICH GIVE IMMENSE RETURNS IN COMING MONTHS TO COME
THIS WAS THE MAIL SEND ON NOV 19 TH 2013
INFOSYS SAFE BET FOR 2014
Last few years have not been great for Infosys investors. But it appears this is about to change in 2014. Infosys stock seems set for considerable gains. Here’s why
Infosys stock has broken out on weekly chart above 3000 and the breakout structure seems robust for huge follow through gains. The only issue: patience.
Here’s the Breakout on weekly chart
What should one do?
Keep Buying the stock between 3000 and 3300 on regular basis and build position for huge gains in next 12 months. As always, there is no certainty in market and if things turn for worse and Infosys stock slips below 50 week ma, then exit and wait for technical to improve.
Wednesday, 18 December 2013
CIPLA A MUST BUY FOR PULL BACK TRADE
RECOMMENDED TO BUY CIPLA FOR A PULL BACK TRADE
BUY CIPLA @ 375 LOT SIZE 500 SL 360 HIT 396 NOW PROFIT 10000 RS
NOW LONG TERM HOLDERS CAN HAVE A DEEP LOOK IN TO THE STOCK
OUR MAIL TO PAID CLIENTS ON 16 TH DEC
Cipla broke out above 360 to New HIGH in August 2012 and 1.5 years later: stock is just at 375 now But this pullback looks like excellent investment opportunity.
Here’s the Cipla Weekly Chart
As you can see in the chart above – Cipla broke out above 360 to New HIGH in August 2012. Post Breakout and lots of consolidation – stock rallied to 450. But in last few months, stock has pulled back and is now at 100 week ma.
Trading Rule: Breakout that has sustained so long becomes excellent buying opportunity at moving average
One can look to buy Cipla at 100 week ma with closing stop loss of 3% below 100 week ma.
BUY CIPLA AT 375 IN FUT FOR SHORT TERM CLOSING SL BELOW 360 IN CASH TGT 400-415 SIZE 500
LONG TERM CLINETS TO CAN ADD STOCK IN THE PORTFOLIO BUY AT 375 SL 350 ON CLOSING BASIC TARGET 430 AND BEYOND THAT FOR FRESH ALL TIME HIGHS OF 475- 500 IN MONTHS TO COME
BUY CIPLA @ 375 LOT SIZE 500 SL 360 HIT 396 NOW PROFIT 10000 RS
NOW LONG TERM HOLDERS CAN HAVE A DEEP LOOK IN TO THE STOCK
OUR MAIL TO PAID CLIENTS ON 16 TH DEC
Cipla broke out above 360 to New HIGH in August 2012 and 1.5 years later: stock is just at 375 now But this pullback looks like excellent investment opportunity.
Here’s the Cipla Weekly Chart
As you can see in the chart above – Cipla broke out above 360 to New HIGH in August 2012. Post Breakout and lots of consolidation – stock rallied to 450. But in last few months, stock has pulled back and is now at 100 week ma.
Trading Rule: Breakout that has sustained so long becomes excellent buying opportunity at moving average
One can look to buy Cipla at 100 week ma with closing stop loss of 3% below 100 week ma.
BUY CIPLA AT 375 IN FUT FOR SHORT TERM CLOSING SL BELOW 360 IN CASH TGT 400-415 SIZE 500
LONG TERM CLINETS TO CAN ADD STOCK IN THE PORTFOLIO BUY AT 375 SL 350 ON CLOSING BASIC TARGET 430 AND BEYOND THAT FOR FRESH ALL TIME HIGHS OF 475- 500 IN MONTHS TO COME
STATE OF MARKET AHEAD OF FOMC AND RBI POLICY TODAY
POSTING SENSEX CHART as its more trustworthy then NIFTY !!
SENSEX 20.5K (Nifty 6100) is the Support I'll be looking for now ..
Two
imp Events Coming this week , FED meeting on 18th night and RBI policy
on 18th Morning which should decide the fate of our Market ..
Now Technically is 20.5K Gets Broken then We'll Slip Fast to 20.1K and 20K levels on Sensex ( 5970-5950 Nifty )
And then Their could be a Fall to 19.5K to 19K levels Very Verly Quicky
(Even in 1-2 days only) That Will be Some Panic Selling & Bears
Will have an Upper Hand that time after a Long time..
BANK NIFTY Supp
@ 11.3-11.1K around and once that 11000 mark is broken then We can see a
Quick 5-10% crack in Bank Nifty ( A 50 BPS rate Hike on 18th is Perfect
Catalyst for the Crackdown ) The 11000 Bank nifty puts Which Are
Trading @ 100-80 Can do 700-1000 also If We Get a 50 BPS rate Hike on
18th ...
Lets Now Look Into the Technical Charts :
SENSEX WEEKY
BANK NIFTY
Some Short Selling Ideas
1. A NIFTY HEAVY WEIGHT ONLY TO CLIENTS
2.ANOTHER NIFTY HEAVY WEIGHT ONLY TO CLIENTS
3. BANK BARODA
Tuesday, 17 December 2013
WIPRO MULTI YEAR BREAKOUT ANOTHER TECHM IN MAKING
" WIPRO " MULTI-YEAR BREAKOUT ...CAN MOVE 30-50% Up in Very Short term
Hope you Remember My Famous TECH-M
Buy Reco @ 1125 & now its 1725+
WIPRO IS NOW ALL SET TO FOLLOW THE PATHS OF TECHMAHINDRA AFTER GIVING 4 YEAR BREAK OUT
Strongly reco TO BUY Wipro @ 510-20 levels for 700 in few months time
Monday, 16 December 2013
GLAXO PHARMA ANOTHER PICTURE PERFECT TECHINCAL MOVES 30 %
WE CAME OUT ON A DETAILED ANALYSIS AND BUY CALL ON GLAXO PHARMA TO PUR PAID CLIENTS ON NOV AND UPDATED IN BLOG ABOUT A PHARAM STOCK ON NOV 18 TH TO BUY GLAXO PHARMA @ 2397 EXPECTING A SHARP RALLY TODAY ON THE BACK OF NEWS STOCK WAS ON FIRE CLOCKED UPPER CIRCUT HIT 2900 MOVE 600 RS ON NO TIME
THIS WAS OUR MAIL TO OUR CLIENTS ON NOV 18
Glaxo Pharma stock has done nothing in last 2-3 years but it seems that’s about to change. Here’s why

Glaxo Pharma stock created a stiff resistance around 2400 for years. It’s only in May 2013- the stock broke past 2400 and since then has been on consolidation drive. The stock seems to be establishing base around 50 week ma (2293) and 2400 which is very bullish and once stock takes off from here – we are looking at multi year bull market in the stock.
What is a MULTI YEAR BULL MARKET
When stocks breakout from a well established multi year resistance: they run a marathon post breakout for years. Here’s one example: Apollo Hospitals
Apollo
Hospitals broke out above 300 in Dec 2009 and then over next 3.5 years:
stock tripled despite overall bad market environment. That’s what
happens when stock breaks out after many years. They can run on their
own.
Glaxo Pharma: Investment worthy
I am not saying Glaxo Pharma will succeed in same way as Apollo Hospitals. It may or it may not but the promise is there for multi year bull market. Remember, we are in a market and there is no certainty of anything. Glaxo Pharma is investment worthy stock and not suitable for trading and short term gains. Having said that – one should look to exit if stock slips below 2190 on closing basis.
THIS WAS THE NEWS WHICH HELPED TO STOCK MOVE IN A BIG WAY
London-listed GlaxoSmithKline plc announced a voluntary open offer to increase its stake in its publicly-listed pharmaceuticals subsidiary in India, GlaxoSmithKline Pharmaceuticals Limited , from 50.7 percent to up to 75 percent at a price of Rs 3,100 per share.
GSK added that it intends to keep the company listed, which means it will not hike its stake any further after the open offer. Securities regulations in India require a minimum public shareholding of 25 percent for a company to maintain a public listing.
The open offer, in which the parent firm intends to buy 2,06,09,774 shares, or 24.3%, of the company, represents a premium of about 26 percent of the stock's closing price on December 13. “For GSK, this transaction will increase exposure to a strategically important market and for our Indian pharmaceuticals subsidiary’s shareholders we believe it offers a good liquidity opportunity at an attractive premium," David Redfern, Chief Strategy Officer, GSK, said in a statement. “GSK has a proud heritage in India. Today’s announcement is a further demonstration of our long-term commitment to the country having increased our holding in our consumer business earlier this year and more recently committed to a significant manufacturing investment.” HSBC Securities is the manager for this open offer.
The transaction will be funded through GSK’s existing cash resources, will be earnings neutral for the first year and accretive thereafter and will not impact expectations for the group’s long-term share buyback programme, the parent company said.
THIS WAS OUR MAIL TO OUR CLIENTS ON NOV 18
Glaxo Pharma stock has done nothing in last 2-3 years but it seems that’s about to change. Here’s why
Glaxo Pharma stock created a stiff resistance around 2400 for years. It’s only in May 2013- the stock broke past 2400 and since then has been on consolidation drive. The stock seems to be establishing base around 50 week ma (2293) and 2400 which is very bullish and once stock takes off from here – we are looking at multi year bull market in the stock.
What is a MULTI YEAR BULL MARKET
When stocks breakout from a well established multi year resistance: they run a marathon post breakout for years. Here’s one example: Apollo Hospitals
Glaxo Pharma: Investment worthy
I am not saying Glaxo Pharma will succeed in same way as Apollo Hospitals. It may or it may not but the promise is there for multi year bull market. Remember, we are in a market and there is no certainty of anything. Glaxo Pharma is investment worthy stock and not suitable for trading and short term gains. Having said that – one should look to exit if stock slips below 2190 on closing basis.
THIS WAS THE NEWS WHICH HELPED TO STOCK MOVE IN A BIG WAY
London-listed GlaxoSmithKline plc announced a voluntary open offer to increase its stake in its publicly-listed pharmaceuticals subsidiary in India, GlaxoSmithKline Pharmaceuticals Limited , from 50.7 percent to up to 75 percent at a price of Rs 3,100 per share.
GSK added that it intends to keep the company listed, which means it will not hike its stake any further after the open offer. Securities regulations in India require a minimum public shareholding of 25 percent for a company to maintain a public listing.
The open offer, in which the parent firm intends to buy 2,06,09,774 shares, or 24.3%, of the company, represents a premium of about 26 percent of the stock's closing price on December 13. “For GSK, this transaction will increase exposure to a strategically important market and for our Indian pharmaceuticals subsidiary’s shareholders we believe it offers a good liquidity opportunity at an attractive premium," David Redfern, Chief Strategy Officer, GSK, said in a statement. “GSK has a proud heritage in India. Today’s announcement is a further demonstration of our long-term commitment to the country having increased our holding in our consumer business earlier this year and more recently committed to a significant manufacturing investment.” HSBC Securities is the manager for this open offer.
The transaction will be funded through GSK’s existing cash resources, will be earnings neutral for the first year and accretive thereafter and will not impact expectations for the group’s long-term share buyback programme, the parent company said.
S&P500: THE REAL PICTURE

When we follow market closely on day-2-day basis, we miss the big picture. Here’s one fact: S&P500 has not seen even a 10% correction since last 2 years. That’s how strong the market has been. But amidst all the strength: What has market actually done?
Here’s S&P500 Weekly Chart: Is market going to Moon
In 2012, S&P500 built a base around 50 week ma: tested thrice and then took off. In 2013: it did not even correct to 50 week ma even once. It’s a perfect chart that shows market took off in a major major bullish way.
Here’s the S&P500 Daily Chart
In 2013, the market exhibited huge strength and S&P500 saw huge buying interest on even minor corrections to 100 dma. So, that means decline to 100 dma turned out to be good buying opportunity. The message: market is going Higher
BUT WHAT IS THE BIG PICTURE
S&P500 moving up on easy money of QE. Trend persists much longer than one can imagine. S&P500 is in solid uptrend. Is that the Big picture? We all can also debate how this will all end but we again are missing an important point: What has market achieved by moving like this in last two years
The Big Picture is the Chart below:
S&P500 is Trading at New HIGH and it has broken out above double top resistance of 1530-1560. Post Breakout, S&P500 did pullback to 1560 before taking off and rallying to 1800. Now, the Law of Breakout says that S&P500 may pullback either to 1530-1560 completely or a moving average like 100 week ma. Since, S&P500 has moved a lot in last two years, it’s quite likely that S&P500 may stall, build a fresh base at 1530-1560 before launching another upmove. Now, I am sure the decline to 1530-1560 may create anxiety and nervousness and End of Bull market call: but remember market may just be following a simple script of Breakout. That’s one big picture, traders should not keep an eye off.
Market will do what it has to do, we can only guess. The Big picture level to remember: S&P500 has broken out above CY2000 and CY2007 High of 1530-1560 and pullback to those levels cannot be ruled out.
Subscribe to:
Posts (Atom)







